preeclampsia
New data has demonstrated that DNA fragment size differences that discriminate preeclampsia from healthy controls can be detected using a lower-cost PCR method.
A retrospective analysis found levels of lipid-based biomarkers such as eicosanoids and sphingolipids were linked with risk of the condition.